Trial Profile
Open Label Macugen for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2014
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Macular degeneration
- Focus Therapeutic Use
- 16 Sep 2014 New trial record